Holotype HLA v3.0.1 is now CE-IVD certified!
Omixon is pleased to announce that the latest Holotype HLA protocol version (v3.0.1) has received a CE-IVD certificate that complies with the IVD Directive 98/79/EC allowing commercialization of the new version products as IVD in Europe. The new Holotype HLA v3.0.1 kit includes pre-mixed PCR amplification reagents that reduce...